Article Information
PubMed
Print ISSN
Online ISSN
History
- Received March 31, 2011
- Accepted July 25, 2011
- Published online September 19, 2011.
Article Versions
- Earlier version (July 26, 2011 - 09:58).
- Earlier version (August 3, 2011 - 06:28).
- Earlier version (August 5, 2011 - 06:36).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- T. Stevens,
- K. Ekholm,
- M. Gränse,
- M. Lindahl,
- V. Kozma,
- C. Jungar,
- T. Ottosson,
- H. Falk-Håkansson,
- A. Churg,
- J. L. Wright,
- H. Lal and
- A. Sanfridson
- AstraZeneca AB, Lund, Sweden (T.S., K.E., M.G., M.L., V.K., C.J., T.O., H.F.-H., H.L., A.S.); and Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada (A.C., J.L.W.)
- Address correspondence to:
Dr. Harbans Lal, Clinical Early Development, Respiratory and Inflammation Therapy Area, AstraZeneca R&D Mölndal, SE-43183 Mölndal, Sweden. E-mail: harbans.lal{at}astrazeneca.com
Statistics from Altmetric.com
Article usage
In this issue
Preclinical Pharmacology of AZD9668, a Novel NE Inhibitor
